Pharma & Biotech

Recent developments at Anixa Biosciences point to significant progress across its oncology pipeline. The company's latest annual shareholder meeting served...

Pharmaceutical giant Eli Lilly is making a substantial long-term commitment to China, targeting the nation as its next major growth...

The German pharmaceutical and agricultural giant Bayer finds itself at a critical juncture. Its immediate prospects hinge on two pivotal...

Bioage Labs is capturing significant attention from major investment banks. As the biotechnology firm advances its pipeline targeting age-related metabolic...

Investors in Merck are grappling with uncertainty following the U.S. market entry of generic competitors for Mavenclad, a key multiple...

In a notable display of conviction, two senior executives at the German pharmaceutical and life sciences giant Bayer AG recently...

The German pharmaceutical packaging specialist Gerresheimer finds itself navigating its most severe corporate turmoil in recent memory. A combination of...

Biotechnology firm Tevogen Bio Holdings is embarking on a significant corporate transformation, centered on a comprehensive overhaul of its executive...

Today's release of BioNTech's full-year 2025 financials is drawing investor attention away from quarterly earnings and toward the company's evolving...

The pharmaceutical sector is bracing for potential margin compression after Novo Nordisk signaled aggressive price reductions for its blockbuster GLP-1...